Hitachi Constructs Japan’s First Platform for Integrated Management of Cell and Tracing Information throughout the Value Chain for Regenerative Medicine Products through Collaborative Creation with Alfresa and Others Hitachi, Ltd. (TSE:6501) has constructed a platform for the integrated management of cell and tracing information throughout the value chain, from cell collection, through production and transport, to the administration of regenerative August 31, 2020 News